蒋(
Zhifei Biological Products Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Recombinant COVID-19 Vaccine (CHO Cell) | COVID-19 Prevention | Marketed |
| Recombinant Tuberculosis Fusion Protein (EC) - Yika | TB Infection Diagnosis | Marketed |
| Mycobacterium vaccae for Injection - Weika | TB Prevention & Adjunctive Therapy | Marketed |
| CA111 Injection | Overweight or Obesity | Clinical |